Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: LUPUS ERITEMATOSO SYNDROME; Information has been received from the Agency on 24-SEP-2019, concerning to a female patient with age reported as 16 (units not provided). The patient''s concurrent conditions, medical history and concomitant medications were not reported. On an unspecified date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (manufacturer unknown), dose reported as 4 (units not reported) (strength, frequency, route of administration, anatomical location, lot #, expiration date were not provided) as prophylaxis. On an unspecified date, the patient experienced lupus erythematous syndrome (systemic lupus erythematosus) and the outcome was fatal. It was unknown if an autopsy was performed, and the cause of death was not reported. The causal relationship between therapy with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (manufacturer unknown) and the event was not provided.
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166